Neoadjuvant Cobimetinib and Atezolizumab with or Without Vemurafenib for High-Risk Operable Stage III Melanoma: the Phase II NeoACTIVATE Trial
Tina J. Hieken,Garth D. Nelson,Thomas J. Flotte,Eric P. Grewal,Jun Chen,Robert R. McWilliams,Lisa A. Kottschade,Lu Yang,Evidio Domingo-Musibay,Roxana S. Dronca,Yiyi Yan,Svetomir N. Markovic,Anastasios Dimou,Heather N. Montane,Courtney L. Erskine,Mara A. Piltin,Daniel L. Price,Samir S. Khariwala,Jane Hui,Carrie A. Strand,Susan M. Harrington,Vera J. Suman,Haidong Dong,Matthew S. Block NATURE COMMUNICATIONS（2024）
AI 理解论文
溯源树
样例
